Нейромедиаторы и нейропептиды — биомаркеры метаболических нарушений при ожирении
жүктеу/скачать 309,4 Kb. Pdf көрінісі
|
ProblemyEndokrinologii 2018 04 258
| Physiol Behav
. 2016;153:47-55. doi: 10.1016/j.physbeh.2015.10.019 43. Jeong JK, Kim JG, Kim HR, et al. A role of central NELL2 in the regulation of feeding behavior in rats. Mol Cells . 2017;40(3):186- 194. doi: 10.14348/molcells.2017.2278 44. Vehapoglu A, Turkmen S, Terzioglu S. Alpha-melanocyte-stimu- lating hormone and agouti-related protein: do they play a role in appetite regulation in childhood obesity? J Clin Res Pediatr Endo- crinol . 2016;8(1):40-47. doi: 10.4274/jcrpe.2136 45. Messina G, Viggiano A, Tafuri D, et al. Role of orexin in obese pa- tients in the intensive care unit. J Anesth Clin Res . 2014;5(3):395. doi: 10.4172/2155-6148.1000395 46. Morello G, Imperatore R, Palomba L, et al. Orexin-A represses satiety-inducing POMC neurons and contributes to obesity VIA stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A . 2016;113(17):4759-4764. doi: 10.1073/pnas.152130411 47. Nixon JP, Mavanji V, Butterick TA, et al. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev . 2015;20:63-73. doi: 10.1016/j.arr.2014.11.001 48. Nebigil CG. Prokineticin is a new linker between obesity and car- diovascular diseases. Front Cardiovasc Med . 2017;4:20. doi: 10.3389/fcvm.2017.00020 49. Gardiner JV, Bataveljic A, Patel NA, et al. Prokineticin 2 is a hy- pothalamic neuropeptide that potently inhibits food intake. Dia- betes . 2010;59(2):397-406. doi: 10.2337/db09-119 50. Sarfati J, Guiochon-Mantel A, Rondard P, et al. A comparative phenotypic study of kallmann syndrome patients carrying mono- allelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab . 2010;95(2):659-669. doi: 10.1210/jc.2009-0843 51. Beale K, Gardiner JV, Bewick GA, et al. Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. Br J Pharmacol . 2013;168(2):403-410. doi: 10.1111/j.1476-5381.2012.02191.x 52. Fang P, Yu M, Gu X, et al. Circulating galanin and galanin like pep- tide concentrations are correlated with increased triglyceride con- centration in obese patients. Clin Chim Acta . 2016;461:126-129. doi: 10.1016/j.cca.2016.07.019 53. Yang JA, Yasrebi A, Snyder M, Roepke TA. The interaction of fast- ing, caloric restriction, and diet-induced obesity with 17beta-estra- diol on the expression of KNDy neuropeptides and their receptors in the female mouse. Mol Cell Endocrinol . 2016;437:35-50. doi: 10.1016/j.mce.2016.08.008 54. Yan Y, Tian L, Xiang X, et al. Chronic gastric electrical stimula- tion leads to weight loss via modulating multiple tissue neuropep- tide Y, orexin, alpha-melanocyte-stimulating hormone and oxyto- cin in obese rats. Scand J Gastroenterol . 2016;51(2):157-167. doi: 10.3109/00365521.2015.1069391 55. Sekar R, Wang L, Chow BK. Central control of feeding behavior by the secretin, PACAP, and glucagon family of peptides. Front Endo- crinol (Lausanne) . 2017;8:18. doi: 10.3389/fendo.2017.00018 56. Shibue K, Yamane S, Harada N, et al. Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroen- docrine K cells in response to fat ingestion. Am J Physiol Endocri- nol Metab . 2015;308(7):E583-591. doi: 10.1152/ajpendo.00543.2014 57. Vu JP, Larauche M, Flores M, et al. Regulation of appetite, body composition, and metabolic hormones by vasoactive intestinal poly- peptide (VIP). J Mol Neurosci . 2015;56(2):377-387. doi: 10.1007/s12031-015-0556-z 58. Martinez VG, O’Driscoll L. Neuromedin U: a multifunctional neu- ropeptide with pleiotropic roles. Clin Chem . 2015;61(3):471-482. doi: 10.1373/clinchem.2014.231753 DOI: http://dx.doi.org/10.14341/probl9466 REVIEW ПРОБЛЕМЫ ЭНДОКРИНОЛОГИИ 2018. — Т. 64 — №4. — С. 258—269 269 59. Li J, Song J, Zaytseva YY, et al. An obligatory role for neurotensin in high-fat-diet-induced obesity. Nature . 2016;533(7603):411-415. doi: 10.1038/nature17662 60. Sam AH, Sleeth ML, Thomas EL, et al. Circulating pancreatic poly- peptide concentrations predict visceral and liver fat content. J Clin Endocrinol Metab . 2015;100(3):1048-1052. doi: 10.1210/jc.2014-3450 61. Cabral A, Lopez Soto EJ, Epelbaum J, Perello M. Is ghrelin syn- thesized in the central nervous system? Int J Mol Sci . 2017;18(3). doi: 10.3390/ijms18030638 62. Collden G, Tschop MH, Muller TD. Therapeutic potential of tar- geting the ghrelin pathway. Int J Mol Sci . 2017;18(4). doi: 10.3390/ijms18040798 63. Zigman JM, Jones JE, Lee CE, et al. Expression of ghrelin re- ceptor mRNA in the rat and the mouse brain. J Comp Neurol . 2006;494(3):528-548. doi: 10.1002/cne.20823 64. Kohno D, Sone H, Minokoshi Y, Yada T. Ghrelin raises [Ca2+] i via AMPK in hypothalamic arcuate nucleus NPY neurons. Bio- chem Biophys Res Commun . 2008;366(2):388-392. doi: 10.1016/j.bbrc.2007.11.166 65. Yang SY, Lin SL, Chen YM, et al. A low-salt diet increases the ex- pression of renal sirtuin 1 through activation of the ghrelin recep- tor in rats. Sci Rep . 2016;6:32787. doi: 10.1038/srep32787 66. Yasrebi A, Hsieh A, Mamounis KJ, et al. Differential gene regula- tion of GHSR signaling pathway in the arcuate nucleus and NPY neurons by fasting, diet-induced obesity, and 17beta-estradiol. Mol Cell Endocrinol . 2016;422:42-56. doi: 10.1016/j.mce.2015.11.007 67. Deck CA, Honeycutt JL, Cheung E, et al. Assessing the functional role of leptin in energy homeostasis and the stress response in ver- tebrates. Front Endocrinol (Lausanne) . 2017;8:63. doi: 10.3389/fendo.2017.00063 68. Schaab M, Kratzsch J. The soluble leptin receptor. Best Pract Res Clin Endocrinol Metab . 2015;29(5):661-670. doi: 10.1016/j.beem.2015.08.002 69. Pedroso JA, Silveira MA, Lima LB, et al. Changes in leptin signal- ing by SOCS3 modulate fasting-induced hyperphagia and weight regain in mice. Endocrinology . 2016;157(10):3901-3914. doi: 10.1210/en.2016-1038 70. Page-Wilson G, Meece K, White A, et al. Proopiomelanocortin, agouti-related protein, and leptin in human cerebrospinal fluid: cor- relations with body weight and adiposity. Am J Physiol Endocrinol Metab . 2015;309(5):E458-E465. doi: 10.1152/ajpendo.00206.2015 жүктеу/скачать 309,4 Kb. Достарыңызбен бөлісу:
|